MICROALLIANCE GROUP INC.
MALGAbout the company
Microalliance Group Inc. develops and sells coffee and liquor products primarily in the People's Republic of China. It offers coffee products, including Chinese black tea, premium black coffee, and other coffee products. The company sells its coffee products wholesale to retail partners and corporate customers, as well as directly to consumers through its e-commerce channels.
Investment snapshot
Positive
7
BUY / PASS
Neutral / negative
1 / 8
NEUTRAL / FAIL
Median fair value
$0.12
-92.0% vs price
Models with upside
0 / 17
Positive margin of safety
Strongest signal
9 of 12 pass — Graham, Buffett and Lynch object
Key risk
All 13 investors flag MALG's valuation
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | PASS | FAIL | FAIL · Rank #945 (Top 30.5%) | PASS | PASS | PASS | FAIL | BUY | FAIL | PASS | FAIL | PASS | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | -782.4% | -316.7% | N/A | -1400.0% | N/A | -1150.0% | -3650.0% | -200.0% | -200.0% | -1150.0% | -2042.9% | -1150.0% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Market data at 2026-11-01 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Market data at 2026-11-01 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-31 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-31 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage75% pass✓ 12✗ 3▾
9 of 12 pass — Graham, Buffett and Lynch object
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.00, IC: N/A✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0✓Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities11.12✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=0.0x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.0005; #329/4210 (top 7.8%)✓AsnessTop 30% of eligible cross-section - Efficiency75% pass✓ 9✗ 2▾
6 of 8 pass — Piotroski and Akre object
Current Ratio11.12✓Graham>= 2.0ROIC (3-5 yr avg)72.5%✓Buffett> 10%ROIC - WACC+62.5%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)92.4%✓Greenblatt> 25%Current Ratio Change YoY0.26 -> 11.12✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.22x -> 1.21x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities11.12✓Dreman> 1.5Return on Invested Capital69.5%✓Munger> 15%ROIC (high and growing)FY2019: ROIC=unavailable; FY2020: ROIC=unavailable; FY2021: ROIC=69.5%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC69.5% (RR=100% x ROIC=69.5%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)1/1 years above 12% (latest 69.5%)✓SleepROIC > 12% in a majority of years
Where It Falls Short
- Valuation0% pass✗ 28▾
All 13 investors flag MALG's valuation
Price / 3-yr avg EPS180.0x✗Graham<= 15xPrice-to-Book Ratio32.4x✗Graham<= 1.5xP/E x P/B5,824.4✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 55.6x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value2.7%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=2.7%, ROC=92.4%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS55.6x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)709.3x✗Dreman< 8xPrice / Book Value per Share32.4x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=55.6x, OE Yield=2.0%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=55.6x, FCF Yield=0.1%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=55.6x, P/B=32.4x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-1100.0% (IV=$0.12 vs Price=$1.50)✗Marks>= 20% below intrinsic valuePrice / FCF per Share780.7x✗Ackman<= 25Price vs. Trailing Low7109% of trailing low ($0.02)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+2.04%; #2719/6340 (top 42.9%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.0309; #5087/6449 (top 78.9%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS55.6x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share32.47x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.0409; #4629/5247 (top 88.2%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+0.13%; #2518/4519 (top 55.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-14.77%; #3700/6202 (top 59.7%)✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 3✗ 10▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 55.6x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 21353.0% vs Rev: 3030.7%✗LynchInventory growth < Revenue growthEPS Growth Direction$-0.00 (2019) -> $0.03 (2021)✓DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency1/3 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth1493.7%✓Ackman>= 5%Positive EPS Growth Frequency1/2 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 86.9% -> 72.1%, operating margin -15.8% -> 66.5%✓SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Valuation models0% pass✗ 10▾
MALG overvalued: all 10 models price fair value below $1.50 (median $0.12)
Graham fair value$0.17✗Graham-782.4% margin vs $1.50Buffett fair value$0.36✗Buffett-316.7% margin vs $1.50Greenblatt fair value$0.10✗Greenblatt-1400.0% margin vs $1.50Dreman fair value$0.12✗Dreman-1150.0% margin vs $1.50Munger fair value$0.04✗Munger-3650.0% margin vs $1.50Pabrai fair value$0.50✗Pabrai-200.0% margin vs $1.50Akre fair value$0.50✗Akre-200.0% margin vs $1.50Marks fair value$0.12✗Marks-1150.0% margin vs $1.50Ackman fair value$0.07✗Ackman-2042.9% margin vs $1.50Templeton fair value$0.12✗Templeton-1150.0% margin vs $1.50 - Profitability25% pass✓ 14✗ 21▾
12 of 16 flag MALG's profitability — Graham, Buffett, Lynch +9 more
Positive EPS (10 years)1/7 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)1/7 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)66.1%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$18.7M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 55.6x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE66.1%✓Lynch> 15%EBIT / Enterprise Value2.7%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=2.7%, ROC=92.4%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets60.26%✓PiotroskiROA > 0ROA Change YoY-64.36% -> 60.26% (delta: +124.61%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=4.16%, ROA=60.26%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY85.2% -> 72.1%✗PiotroskiImproved YoYPre-Tax Income / Revenue66.5%✓Dreman>= 8%Net Income / Shareholders' Equity66.1%✓Dreman> 12%Margin of SafetyP/E=55.6x, P/B=32.4x✗PabraiP/B < 1.5 or P/E < 15Return on Equity66.1% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value-1100.0% (IV=$0.12 vs Price=$1.50)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency1/3 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue66.5%✓Ackman>= 15%Net Income / Shareholders Equity66.1%✓Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-15.8% (2019) -> 66.5% (2021)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 86.9% -> 72.1%, operating margin -15.8% -> 66.5%✓SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+2.04%; #2719/6340 (top 42.9%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+87.03%; #201/3702 (top 5.4%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity+66.12%; #151/5226 (top 2.9%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.5216; #4959/5884 (top 84.3%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Cash Flow40% pass✓ 5✗ 7▾
6 of 10 flag MALG's cash flow — Piotroski, Dreman, Pabrai +3 more
Free Cash Flow Proxy$18.7M✓BuffettPositive and growingFCF Positive and Growing$1.2M✓LynchPositive and growingOperating Cash Flow$1.3M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=4.16%, ROA=60.26%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)709.3x✗Dreman< 8xP/E or FCF YieldP/E=55.6x, FCF Yield=0.1%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive3/3 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap0.1%✗Ackman>= 4%Price / FCF per Share780.7x✗Ackman<= 25Positive Operating Cash Flow frequency3/6 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$1.2M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+0.13%; #2518/4519 (top 55.7%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts44% pass✓ 7✗ 9▾
Split decision: 8 FAIL · 6 PASS · 1 BUY · 1 NEUTRAL
Overall verdict✗GrahamFAIL (1/9)✓BuffettPASS (4/9)✗LynchFAIL (3/7)✗GreenblattRank #945✓PiotroskiPASS (F-Score 5)✓DremanPASS (5/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✓AkreBUY (5/6)✗MarksFAIL (2/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1050/2370 (Top 44.3%))✗NeffFAIL (1/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
Business & financials
Financial snapshot: annual FY 2021. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2021
Issued 1.5% of shares last year, 1.5% issued over two.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2021Sources
| FY 2020Sources
| FY 2019Sources
| FY 2018Sources
| FY 2008Sources |
|---|---|---|---|---|---|
| Market Cap | $914.0Mcurrent | $600.0Mest. | $4.8Best. | -- | $95.6Best. |
| Revenue | $37.4M↑3031% | $1.2M↓43% | $2.1M | -- | $4.0K |
| Operating Income | $24.9M↑4176% | -$609.9K↓84% | -$332.2K | -- | -- |
| Net Income | $18.7M↑3074% | -$627.9K↓106% | -$305.1K | -- | -- |
| EPS (Diluted) | $0.03↑2800% | $-0.00 | $-0.00 | -- | -- |
| Gross Margin | 72.1%↓15% | 85.2%↓2% | 86.9% | — | — |
| Operating Margin | 66.5%↑230% | -51.1%↓224% | -15.8% | — | — |
| ROE | 66.1%↑9% | 60.6%↓31% | 87.4% | — | — |
| Total Debt | $14.7K↓77% | $63.5K | -- | -- | -- |
| Shareholders' Equity | $28.2M↑2827% | -$1.0M↓197% | -$349.1K↓628% | -$48.0K | -- |
| Current Ratio | 11.12↑4189% | 0.26↓18% | 0.32 | — | 0.00 |
| Debt / Equity | 0.00↑101% | -0.06 | — | — | — |
| Operating Cash Flow | $1.3M↑3313% | $37.8K↓82% | $211.7K | -- | -$51.3K |
| Free Cash Flow | $1.2M↑3249% | $35.0K↓65% | $100.8K | -- | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Beer & Liquor
MALG vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COCA COLA COKO | $427.0B | $99.25 | $47.9B | $13.1B | 40.7% | 1.37 | 28.7% | 1.46 | 3/9 | 6/9 | 4/7 | 1/3 | F-Score 7 | 3/11 |
| PEPSICO INCPEP | $198.2B | $145.44 | $93.9B | $8.2B | 40.4% | 2.41 | 12.2% | 0.85 | 4/9 | 6/9 | 3/7 | 1/3 | F-Score 5 | 6/11 |
| Anheuser-Busch InBev SA/NVBUD | $167.0B | $84.81 | $59.3B | $6.8B | 7.8% | 0.84 | 26.0% | 0.72 | 1/9 | 1/9 | 3/7 | 1/3 | F-Score 7 | 2/11 |
| DIAGEO PLCDEO | $56.6B | $101.59 | $28.0B | $2.5B | 22.9% | 2.14 | 15.5% | 1.63 | 1/9 | 4/9 | 2/7 | 1/3 | F-Score 4 | 5/11 |
| Keurig Dr Pepper Inc.KDP | $49.5B | $36.34 | $16.6B | $2.1B | 8.1% | 0.63 | 21.5% | 0.64 | 2/9 | 2/9 | 2/7 | 1/3 | F-Score 6 | 2/11 |
| AMBEV S.A.ABEV | $42.5B | $2.76 | $16.1B | $2.8B | 17.6% | 0.04 | 26.4% | 0.96 | 1/9 | 5/9 | 6/7 | 3/3 | F-Score 6 | 4/11 |
| CONSTELLATION BRANDS, INC.STZ | $24.6B | $145.61 | $9.1B | $1.7B | 20.9% | 1.27 | 29.8% | 1.08 | 1/9 | 2/9 | 2/7 | 1/3 | F-Score 5 | 5/11 |
| BROWN FORMAN CORPBF-B | $14.1B | $30.65 | $3.9B | $715.0M | 17.8% | 0.61 | 25.5% | 3.24 | 5/9 | 6/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |